Event
Axxam at the 22nd Drug Discovery Strategic Summit (DDSS)
Lewis Vann
Director | BD & Sales - North America - West
Angela Molteni
Head | Hit & Lead Discovery
Advancing drug discovery requires more than innovative technologies. It calls for integrated scientific strategies, informed decision-making, and effective approaches to overcoming challenges throughout the discovery process.
The 22nd Drug Discovery Strategic Summit (DDSS) brought together professionals from the pharmaceutical and biotechnology industries in San Francisco to explore developments, challenges, and opportunities shaping drug discovery.
Axxam attended the event, represented by Lewis Vann, Director BD & Sales North America – West, and Angela Molteni, Head of Hit & Lead Discovery.
Connecting Science and Strategy in Drug Discovery
From target identification and validation to hit discovery and lead optimization, successful drug discovery depends on connecting biological insights with robust experimental approaches.
At Axxam, we combine expertise in assay development, high-throughput screening, compound profiling, and medicinal chemistry to support drug discovery programs across multiple therapeutic areas.
Our integrated approach helps researchers address complex scientific challenges, generate actionable data, and guide compound progression through early discovery.
Supporting Drug Discovery from Early Research to Lead Optimization
Drug discovery programs face increasing challenges, from identifying promising therapeutic targets to selecting compounds with the right biological and pharmacological properties. By integrating advanced screening technologies, disease-relevant models, and medicinal chemistry expertise, Axxam supports researchers in navigating these complexities, reducing early-stage risks, and making informed decisions throughout the discovery process.
Meet the Axxam Team
Lewis Vann and Angela Molteni attended DDSS 2026, connecting with industry professionals and exchanging perspectives on drug discovery strategies, technologies, and emerging research opportunities.
Interested in exploring how Axxam can support your drug discovery program?